跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSIE ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ROSIE ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack
Approved
STANDARD
ROSIE ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d66d8d73780d0d91
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
d66d8d73780d0d91
Product Name
ROSIE ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack
Artg Id
407771
Artg Name
ROSIE ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2023-09-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1d6c919efd9678a56fae5cb8056266ef.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1bee0f13e74d0c80c9fd68f284e86291.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d66d8d73780d0d91
Type
Standard
Back to TGA Approvals